UNITED STATES NEWS

California, drugmaker partner to produce affordable insulin

Mar 18, 2023, 4:05 PM

DOWNEY, Calif. (AP) — The state of California and a generic drug manufacturer announced a 10-year partnership Saturday to produce affordable, state-branded insulin that they hope will rival longtime producers and push down prices for a medication used by millions of Americans.

The product is not expected on store shelves until at least next year, and it was difficult to predict what effect it would have on a market already shaken by change. Earlier this week another major insulin maker promised steep price cuts as pressure builds on drugmakers and insurers to slash the cost of the drug.

Democratic Gov. Gavin Newsom said he hoped California’s emergence as an insulin-maker would prompt prices to collapse. Research has shown that prices for the drug have more than tripled in the past couple of decades.

“We are intent to make this about market disruption,” Newsom said at a ceremony announcing the pact at a pharmaceutical warehouse near Los Angeles. He called it “a game changer” for 8 million Americans who use insulin to treat diabetes.

Many questions remain. The state and its partner, the nonprofit Civica, have yet to locate a California-based manufacturing facility. Regulatory approvals will be needed. Newsom said a 10- milliliter vial of the state-branded insulin would sell for $30, but it’s possible competitors could slash their prices and undercut the state product.

“Is this perfect? We don’t know yet,” Newsom acknowledged at one point.

Just days ago, President Joe Biden said his administration is focused “intensely” on lowering health care costs, including pressuring pharmaceutical companies to lower the costs of insulin. Legislation enacted last year capped copayments for insulin at $35 per month for Medicare beneficiaries. Biden has proposed extending that cap to all Americans.

Novo Nordisk said Tuesday that it will slash some of its U.S. insulin prices up to 75% starting next year. The announcement comes less than two weeks after rival Eli Lilly said it will drop some of its prices by 70% or more later this year.

Anthony Wright, executive director of Health Access California, a statewide consumer health care advocacy group, welcomed Newsom’s announcement, saying efforts by California and others to develop a competing generic are likely a factor in getting insulin manufacturers to cut their prices.

Still, there are obstacles.

“The work to develop a generic, get FDA approval and set up manufacturing will take real time,” Wright said in an email. “There may even be more time in the effort to get doctors to prescribe the drug, insurers and (pharmacy benefit managers) to include it on their formularies and patients and the public to accept and ask for it.”

There could be other risks. State analysts have warned that California’s entry into the market could prompt other manufacturers to reduce the availability of their drugs, a potential unintended consequence.

State lawmakers approved $100 million for the project last year, with $50 million dedicated to developing three types of insulin and the rest set aside to invest in a manufacturing facility.

Even with the challenges of entering a competitive, established market, Newsom said taxpayers would have “very ample protections.”

If for whatever reason the deal didn’t work out to the state’s benefit, “there’s all kinds of provisions that would allow us to … pull out,” he said.

According to state documents, the proposed program could save many patients between $2,000 and $4,000 a year. In addition, lower costs could result in substantial savings because the state buys the product every year for the millions of people on its publicly funded health plans.

The state also is exploring the possibility of bringing other drugs to market, including the overdose medication Naloxone. The drug, available as a nasal spray and in an injectable form, is considered a key tool in the battle against a nationwide overdose crisis.

“We are not stopping here,” Newsom said.

United States News

Associated Press

Norman Lear, producer of TV’s ‘All in the Family’ and influential liberal advocate, has died at 101

LOS ANGELES (AP) — Norman Lear, the writer, director and producer who revolutionized prime time television with “All in the Family,” “The Jeffersons” and “Maude,” propelling political and social turmoil into the once-insulated world of TV sitcoms, has died. He was 101. Lear died Tuesday night in his sleep, surrounded by family at his home […]

43 minutes ago

Associated Press

White House delays menthol cigarette ban, alarming anti-smoking advocates

WASHINGTON (AP) — White House officials will take more time to review a sweeping plan from U.S. health regulators to ban menthol cigarettes, an unexpected delay that anti-tobacco groups fear could scuttle the long-awaited rule. Administration officials indicated Wednesday the process will continue into next year, targeting March to implement the rule, according to an […]

1 hour ago

Associated Press

New GOP-favored Georgia congressional map nears passage as the end looms for redistricting session

ATLANTA (AP) — A Georgia special session to redraw congressional and legislative voting district maps is likely to end Thursday after a House committee on Wednesday advanced a Republican-favored congressional map that targets Democratic U.S. Rep. Lucy McBath’s current district. However, the wrangling is unlikely to end there, with those who brought the challenges that […]

2 hours ago

President Joe Biden delivers remarks at the White House Tribal Nations Summit at the Department of ...

Associated Press

Biden’s campaign will not commit yet to participating in general election debates in 2024

TUSCALOOSA, Ala. (AP) — President Joe Biden’s campaign is not yet committing to general election debates next year, the latest sign that a staple of modern White House campaigns may not be in play in 2024. Quentin Fulks, Biden’s top deputy campaign manager, told reporters Wednesday that the president’s reelection campaign would “look at the […]

2 hours ago

Associated Press

Nevada grand jury indicts 6 fake Donald Trump electors

RENO, Nev. (AP) — A Nevada grand jury indicted six Republicans who submitted certificates to Congress falsely declaring Donald Trump the winner of the 2020 presidential election in their state, making Nevada the third to seek charges against so-called “fake electors.” Nevada Attorney General Aaron Ford began investigating the fake electors last month. He said […]

2 hours ago

Associated Press

Juanita Castro, anti-communist sister of Cuban leaders Fidel and Raul, dies in Miami at 90

MIAMI (AP) — Juanita Castro, the sister of Cuban rulers Fidel and Raúl Castro who worked with the CIA against their communist government, has died in Miami at 90. Florida had been her home since shortly after fleeing the island nearly 60 years ago. Journalist María Antonieta Collins, who co-wrote Juanita Castro’s 2009 book, “Fidel […]

2 hours ago

Sponsored Articles

(KTAR News Graphic)...

KTAR launches online holiday auction benefitting Boys & Girls Clubs of the Valley

KTAR is teaming up with The Boys & Girls Clubs of the Valley for a holiday auction benefitting thousands of Valley kids.

...

Dierdre Woodruff

Interest rates may have peaked. Should you buy a CD, high-yield savings account, or a fixed annuity?

Interest rates are the highest they’ve been in decades, and it looks like the Fed has paused hikes. This may be the best time to lock in rates for long-term, low-risk financial products like fixed annuities.

Follow @KTAR923...

The 2023 Diamondbacks are a good example to count on the underdog

The Arizona Diamondbacks made the World Series as a surprise. That they made the playoffs at all, got past the Milwaukee Brewers in the NL Wild Card round, swept the Los Angeles Dodgers in the NLDS and won two road games in Philadelphia to close out a full seven-game NLCS went against every expectation. Now, […]

California, drugmaker partner to produce affordable insulin